Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Renard

Showing results (61-70 of 225) with videos related to

Pageof 23
Sort By:
Diabetes Care|December 25, 2003
Aseptic peritonitis revealed through recurrent catheter obstructions in type 1 diabetic patients treated with continuous peritoneal insulin infusionEric Renard, Isabelle Raingeard, Guy Costalat, et al.
Diabetes Research and Clinical Practice|July 4, 2025
Glycemic variability and iatrogenic hypoglycemia: how to resolveLouis Monnier, Claude Colette, Eric Renard, et al.
Diabetes Care|January 1, 2017
Toward Defining the Threshold Between Low and High Glucose Variability in DiabetesLouis Monnier, Claude Colette, Anne Wojtusciszyn, et al.
Diabetes & Metabolism|November 24, 2024
Prevent hypoglycaemia when using automated insulin delivery systems in type 1 diabetes requires near normal glycaemic variabilityLouis Monnier, Claude Colette, Eric Renard, et al.
Diabetes Technology & Therapeutics|September 24, 2009
Efficacy and safety of AIR inhaled insulin compared to insulin lispro in patients with type 1 diabetes mellitus in a 6-month, randomized, noninferiority trialAngel L Comulada, Eric Renard, Masako Nakano, et al.
Scientific Reports|August 12, 2022
Evaluating and mitigating clinical samples matrix effects on TX-TL cell-free performancePeter L Voyvodic, Ismael Conejero, Khouloud Mesmoudi, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 2, 2021
Telemonitoring, Telemedicine and Time in Range During the Pandemic: Paradigm Change for Diabetes Risk Management in the Post-COVID FutureThomas Danne, Catarina Limbert, Manel Puig Domingo, et al.
Diabetes Technology & Therapeutics|May 27, 2011
Assessment of blood glucose predictors: the prediction-error grid analysisSampath Sivananthan, Valeriya Naumova, Chiara Dalla Man, et al.
Diabetes Care|September 22, 2009
Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend studyDenis Raccah, Véronique Sulmont, Yves Reznik, et al.
Diabetes Research and Clinical Practice|April 13, 2018
Switching to insulin glargine 300 U/mL: Is duration of prior basal insulin therapy important?Riccardo C Bonadonna, Eric Renard, Alice Cheng, et al.
Pageof 23

Showing results (61-70 of 225) with videos related to

Sort By:
Pageof 23
Diabetes Care|December 25, 2003
Aseptic peritonitis revealed through recurrent catheter obstructions in type 1 diabetic patients treated with continuous peritoneal insulin infusionEric Renard, Isabelle Raingeard, Guy Costalat, et al.
Diabetes Research and Clinical Practice|July 4, 2025
Glycemic variability and iatrogenic hypoglycemia: how to resolveLouis Monnier, Claude Colette, Eric Renard, et al.
Diabetes Care|January 1, 2017
Toward Defining the Threshold Between Low and High Glucose Variability in DiabetesLouis Monnier, Claude Colette, Anne Wojtusciszyn, et al.
Diabetes & Metabolism|November 24, 2024
Prevent hypoglycaemia when using automated insulin delivery systems in type 1 diabetes requires near normal glycaemic variabilityLouis Monnier, Claude Colette, Eric Renard, et al.
Diabetes Technology & Therapeutics|September 24, 2009
Efficacy and safety of AIR inhaled insulin compared to insulin lispro in patients with type 1 diabetes mellitus in a 6-month, randomized, noninferiority trialAngel L Comulada, Eric Renard, Masako Nakano, et al.
Scientific Reports|August 12, 2022
Evaluating and mitigating clinical samples matrix effects on TX-TL cell-free performancePeter L Voyvodic, Ismael Conejero, Khouloud Mesmoudi, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 2, 2021
Telemonitoring, Telemedicine and Time in Range During the Pandemic: Paradigm Change for Diabetes Risk Management in the Post-COVID FutureThomas Danne, Catarina Limbert, Manel Puig Domingo, et al.
Diabetes Technology & Therapeutics|May 27, 2011
Assessment of blood glucose predictors: the prediction-error grid analysisSampath Sivananthan, Valeriya Naumova, Chiara Dalla Man, et al.
Diabetes Care|September 22, 2009
Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend studyDenis Raccah, Véronique Sulmont, Yves Reznik, et al.
Diabetes Research and Clinical Practice|April 13, 2018
Switching to insulin glargine 300 U/mL: Is duration of prior basal insulin therapy important?Riccardo C Bonadonna, Eric Renard, Alice Cheng, et al.
Pageof 23